T. Voisin et al., Functional and molecular properties of the human recombinant Y4 receptor: Resistance to agonist-promoted desensitization, J PHARM EXP, 292(2), 2000, pp. 638-646
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
After stable transfection of Chinese hamster ovary cells with the human Y4
receptor, clone 29 was isolated and studied for receptor properties. The fo
llowing data were obtained: 1) one class of binding site was identified by
analysis of I-125-human pancreatic polypeptide (hPP) binding to cell membra
nes with a K-d value of 0.26 nM and a B-max value of 1.44 pmol/mg protein;
2) the K-i values for inhibition of I-125-hPP binding by hPP, human peptide
YY (hPYY), human neuropeptide Y (hNPY), and analogs were hPP (0.7 nM), rat
PP (47 nM) < hPYY (94 nM) < h[Leu(31)-Pro(34)]NPY (124 nM) << hNPY = porci
ne NPY(13-36) = rat D-[Trp(32)]NPY (>1 mu M); 3) cross-linking experiments
using I-125-hPP identified a single M-r 60,000 glycosylated Y4 receptor; an
d 4) the natural peptides hPP, hPYY, and hNPY inhibited forskolin-stimulate
d cAMP production in clone 29 cells with EC50 values of 0.56 nM, 218 nM, an
d >1 mM, respectively. The inhibitory effect of hPP was abolished when cell
s were incubated with pertussis toxin, indicating a pertussis toxin-sensiti
ve G(i) protein-mediated event. 5) Exposure of cells to 10 nM hPP for 24 h
resulted in the absence of modification of binding capacity (1.38 versus 1.
44 pmol/mg protein in control cells) or affinity (0.31 versus 0.26 nM in co
ntrol cells); there also was no modification in the potency and efficacy of
hPP in inhibiting forskolin-stimulated cAMP. Immunofluorescence indicated
that the Y4 receptor was not internalized within the cells after 24-h treat
ment with 10 nM hPP. These data support that Y4 receptors are resistant to
agonist-promoted desensitization and internalization. Clone 29 cells provid
e a valuable tool to further characterize the pharmacological aspects of hu
man Y4 receptor.